Skip to main content
. 2016 Jul 8;17(1):66. doi: 10.1186/s10194-016-0657-2

Table 2.

Clinical characteristics, medical treatments and MRI outcome in Trigeminal autonomic cephalalgias patients treated with high frequency cervical spinal cord stimulation treatment

Patient 1 Patient 2 Patient 3
Diagnosis Chronic SUNA Chronic SUNA CCH
Side of pain Left Right Left
Site of pain V1-V2-V3-C2 V3-V2-V1 V1
Pain character Stabbing Stabbing Stabbing
Attack duration 2–600 s 180–300 s 40–180 min
Attack frequency (daily) 30–50 50–60 1–10
Pain severity (VRS) 8–10/10 10/10 10/10
Ipsilateral autonomic features - Ptosis
- Rhinorrhoea
- Facial oedema
- Facial redness
- Blocked nose
- Rhinorrhoea
- Facial oedema
- Facial redness
- CI
- Lacrimation
- Rhinorrhoea
- Facial sweating
Migrainous symptoms Yes Yes No
Cutaneous triggers Yes No No
Background pain Yes Yes Yes
Effect of indometacin None None None
Failed treatments - Lamotrigine
- Carbamazepine
- Oxcarbazepine
- Prednisolone
- Topiramate
- Gabapentin
- Pregabalin
- Duloxetine
- Amitriptyline
- Flunarizine
- Lamotrigine
- Carbamazepine
- Gabapentin
- Pregabalin
- Amitriptylinea
- Oxygen
- Sumatriptan sc
- Verapamil
- Lithium
- Prednisolone
- Gabapentin
- Pregabalin
- Topiramate
- Melatonin
- Indometacin
- Baclofen
- Sodium
Valproate
- Levetiracetam
- GONB
- MCNB
- SPG block
- IV lidocaine
MRI brain Normal Normal Normal

CCH chronic cluster headache; CI conjunctival injection, GONB greater occipital nerve block, IV intravenous, MCNB multiple cranial nerve block, SC subcutaneous, SPG sphenopalatine ganglion, SUNA short-lasting unilateral neuralgiform headache attacks with autonomic symptoms, VRS verbal rating scale, V1 ophthalmic trigeminal division, V2 maxillary trigeminal division, V3 mandibular trigeminal division

aPatient 2 declined any further pharmacological treatments